Treatment duration of brigatinib in patients enrolled in the international expanded access program (EAP)

被引：0
|
作者：
Lin, M. M. [1 ]
Pan, X. [1 ]
Hou, P. [1 ]
Allen, S. [1 ]
Baumann, P. [1 ]
Hochmair, M. J. [2 ,3 ]
机构：
[1] Millennium Pharmaceut Inc, Cambridge, MA USA
[2] Otto Wagner Spital, Dept Resp & Crit Care Med, Vienna, Austria
[3] Otto Wagner Spital, Ludwig Boltzmann Inst COPD & Resp Epidemiol, Vienna, Austria
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
108O
引用
收藏
页码：42 / 42
页数：1
相关论文
共 50 条
  • [1] Avelumab treatment of metastatic merkel cell carcinoma (mMCC): Updated findings from Australian patients enrolled in an expanded access program(EAP)
    Sandhu, Shahneen
    Kasturi, Vijay
    Guminski, Alex
    Steer, Christopher
    Atkinson, Victoria
    Nordman, Ina
    Tobin, Peter
    Reed, Josh
    Costa, Nuno
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 184 - 184
  • [2] Expanded access program (EAP) to investigational drugs.
    Talarico, L
    Pazdur, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 519S - 519S
  • [3] Pembrolizumab Expanded Access Program (EAP) in Taiwan for patients with progressive advanced melanoma after prior ipilimumab treatment
    Yang, C-K.
    Liu, J-H.
    Lin, C-C.
    Liu, T-C.
    Cheng, P-T.
    Lin, C-Y.
    Hu, H-T.
    Cao, C-R.
    Huang, W-T.
    Chen, L-P.
    Chang, W-C.
    ANNALS OF ONCOLOGY, 2016, 27
  • [4] AUSTRALIAN BREAST CANCER PATIENTS ENROLLED IN THE LAPATINIB EXPANDED ACCESS PROGRAM (LEAP)
    Lynch, J.
    Boyle, F.
    Wilkin, N.
    Hague, C.
    ANNALS OF ONCOLOGY, 2010, 21 : 102 - 102
  • [5] Imatinib expanded access program (EAP):: Results of treatment in >7000 patients with chronic myeloid leukemia (CML).
    Van Hoomissen, IC
    Hensley, ML
    Krahnke, T
    Capdeville, R
    Ben-Am, M
    Gathmann, I
    BLOOD, 2003, 102 (11) : 906A - 906A
  • [6] Results of the Afatinib Expanded Access Program (EAP): Efficacy and Safety
    Kim, E. S.
    Halmos, B.
    Kohut, I. F.
    Patel, T.
    Rostorfer, R. D.
    Spira, A. I.
    Cseh, A.
    McKay, J.
    Wallenstein, G.
    Mileham, K. F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S40 - S40
  • [7] Safety of Everolimus by Treatment Duration in Patients With Advanced Renal Cell Cancer in an Expanded Access Program
    van den Eertwegh, Alfonsus J. M.
    Karakiewicz, Pierre
    Bavbek, Sevil
    Rha, Sun Young
    Bracarda, Sergio
    Bahl, Amit
    Ou, Yen-chuan
    Kim, Dennis
    Panneerselvam, Ashok
    Anak, Oezlem
    Gruenwald, Viktor
    UROLOGY, 2013, 81 (01) : 143 - 149
  • [8] Avelumab treatment of Australian patients with metastatic Merkel cell carcinoma (mMCC): Experience from an expanded access program (EAP)
    van Hagen, Tom
    Sandhu, Shahneen
    Kasturi, Vijay
    Steer, Christopher
    Khoo, Chloe
    Nordman, Ina
    Hennessy, Meliessa
    Hildemann, Steven
    Reed, Josh
    Hariharan, Subramanian
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 173 - 174
  • [9] Teprotumumab for the Treatment of Thyroid Eye Disease: Clinical Experience from Expanded Access Program (EAP)
    Wang, Yao
    Mester, Tunde
    Ugradar, Shoaib
    Douglas, Raymond
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [10] Baseline Characteristics Of Patients With Transthyretin Cardiac Amyloidosis Enrolled In The Patisiran Expanded Access Program
    Saha, Naveen
    Shah, Zubair
    Hanna, Mazen A.
    Nikolova, Andriana
    Moffitt, Colleen
    Summers, Catherine
    Capocelli, Kelley
    Drachman, Brian M.
    JOURNAL OF CARDIAC FAILURE, 2024, 30 (01) : 156 - 156
12345